Clinical Research Directory

Inclusion Criteria: * Age \>= 21 years of age * Report concurrent use of commercial (medical or recreational) smoked cannabis and THC vaping cartridges for at least 3 months prior to enrollment * Report smoking cannabis and THC- vaping liquid use at the potency level of the study product at least weekly (4x/month) * Report of not currently trying to become pregnant (females). Women of childbearing potential must be willing to provide a urine sample and test negative prior to receiving any study-related products/procedures * Willing to complete a THC saliva test to check for recent use (NarcoCheck Ref#:NCE-STHC-1) and semi -quantitative urinary tetrahydrocannabinol-carboxylic acid (THCA) rapid test (NarcoCheck® THC PreDosage) during baseline testing, prior to receiving any study-related products * Participant must understand the investigational nature of this study and sign an Institutional Review Board approved written informed consent form prior to receiving any study related procedure Exclusion Criteria: * • Illegal or non-prescription drug use within the past 90 days. As detected by NacroCheck® Évolutive® (detection in human urine of the 12 most currently abused drugs) at the first session and prior to receiving any study product * Report 2 or more drinking occasions/week with 4 or more drinks/occasion * Report of daily nicotine use * Current or prior diagnosis of any psychotic disorders * Current or prior diagnosis of chronic heart conditions * Current or prior diagnosis of any respiratory condition * Pregnant or currently trying to become pregnant (females) * Detection level 4-5 (\>300 ng/mL) from a semi-quantitative urinary THCA rapid test (NarcoCheck® THC PreDosage) * Unwilling or unable to follow protocol requirements * Any condition which in the Investigator's opinion deems the participant an unsuitable candidate for participation